Safety and Efficacy of ES-NK Cell Injection in the Treatment of Refractory Lupus Nephritis: an Early Clinical Study

NCT07412210 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythenlatosus Nephritis

Interventions

BIOLOGICAL: AXA-NK02

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]